J E Shively

Numerical selection of optimal tumor imaging agents with application to engineered antibodies.

L E Williams, A A Raubitschek, J. Wong, 2001, Cancer biotherapy & radiopharmaceuticals.

High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.

S S Gambhir, M E Phelps, L E Williams, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers

A. Gazdar, F. Kaye, J. Mulshine, 1992, International journal of cancer.

Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.

J M Esteban, L E Williams, A A Raubitschek, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.

J M Esteban, L E Williams, M. Neumaier, 1995, Cancer research.

Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications.

A A Raubitschek, A. Wu, J. Shively, 2001, Journal of immunological methods.

Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.

L E Williams, R Fischer, M. Neumaier, 1996, Immunotechnology : an international journal of immunological engineering.

Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.

J M Esteban, L E Williams, A A Raubitschek, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts.

L E Williams, J. Wong, A. Wu, 1996, Cancer research.